American Diabetes Association Says Mifepristone Shown To Reduce A1C In Patients With Difficult-To-Control Type 2 Diabetes And Hypercortisolism
Refinitiv1분 미만 읽기
AMERICAN DIABETES ASSOCIATION: MIFEPRISTONE SHOWN TO REDUCE A1C IN PATIENTS WITH DIFFICULT-TO-CONTROL TYPE 2 DIABETES AND HYPERCORTISOLISM
이 뉴스를 읽으려면 로그인하거나 평생 무료 계정을 만드십시오